Embed Size (px)
Citation preview
8/2/2019 Programa 7 Neuropsych (01!03!2012)
http://slidepdf.com/reader/full/programa-7-neuropsych-01032012 1/2
Practical focus on the diagnosis
and treatment of the Neuropsychiatryand neuropsychological aspects of
HIV-infected patients.
InformationVenue AUDITORIUM IDEC
Universitat Pompeu Fabra
Balmes, 132-134. 08008 Barcelona. Spain
Information and Abstractswww.neuropsychiatry.com
RegistrationRegistration fees 540 €
Include: Participation at the scientic sessions, ofcial
Symposium printed materials, coffee and lunch breaks,
8% VAT included.
Deadline: May 18th 2012
a) On line: www.neuropsychiatry-hiv.com
b) By e-mail. Please, send registration form and bank transfer copy
Payment:
a) On line: Credit card or bank transfer
b) Bank transfer to:
C&C–Symposium on Neuropsychiatry & HIV
IBAN account: ES6721003447712200082884
SWIFT: CAIXESBBXXXIt is important to state the participant’s name on the bank
transfer.
SecretaryC&C, Congresos y Convenciones
Contact Person: Ruth Boza
Saragossa, 132-134.
08023 Barcelona (Spain)
Tel: +34 934173113. Fax: +34 934184203
5th
Barcelona, May 24th and 25th 2012www.neuropsychiatry-hiv.com
Scientifc sponsorship in previous years AIDS Spanish National Plan
Internacional
Symposium on
Neuropsychiatry HIV
8/2/2019 Programa 7 Neuropsych (01!03!2012)
http://slidepdf.com/reader/full/programa-7-neuropsych-01032012 2/2
Preliminary Program
Thursday 24th May 2012
08:30-09:00 amDelivery of documentation
09:00-09:30 amOpening
09:30-10:30 amDiagnosis and Management of Anxiety Disorders.Milton Wainberg
10:30-11:00 amCoffee Break
11:00-12:00 pmScreening for Neurocognitive Impairment:A Practical Approach.Paola Cinque
12:00-01:00 pmSpectrum and Management of Sexual Dysfunction.José Catalán
01:00-02:30 pmLunchtime
02:30-03:30 pmAntiretroviral Therapy for Prevention and Management of HIV-Associated Neurocognitive Impairment: What is reallychanging?Scott Letendre
03:30-04:30 pmClinical Case Studies SessionClinicians are invited to send proposals for real cases of HIV+
patients with neurocognitive or psychiatric aspects of outstandingclinical or therapeutic interest. Cases selected for oralpresentation will be awarded with a certicate and a small econo-mical compensation.
Friday 25th May 2012
08:30-09-30 amSafety and Compliance of Psychopharmacological Therapy.Emili Fernández-Egea
09:30-11:00 amControversial Issues on Antiretroviral Therapy andNeurocognitive Impairment.Asymptomatic Neurocognitive Impairment: Illussion or Reality?Alan Winston
Protease-Inhibitor Monotherapy: Friend or Foe?José R. Arribas
11:00-11:30 pmCoffee Break
11:30-13:00 pmWorkshops
Workshop1:
Neurocognitive Screening in HIV Infection: How to
Implement this Assessment in the Busy Clinic?José A. Muñoz-Moreno
Workshop2:Application of the mindfulness-based stress reduc-tion program in subjects living with HIV infectionCarmina R. Fumaz
13:00-13:15 pmClosure and Farewell
During the symposium authors are invited to communicate part of their clinical and research work as poster presentations. Studiesalready published or presented in recent conferences are alsoaccepted.
Organizing CommitteeEsteban Martínez, MD.Infectious Diseases. Hospital Clínic. Barcelona. SpainJordi Blanch, MD.Psychiatry. Hospital Clínic. Barcelona. Spain
Scientifc Comittee & SpeakersAndrea Antinori, MD. Rome. ItalyJosé R. Arribas, MD. Madrid. SpainJosé Catalán, MD. London. UKPaola Cinque, MD. Milan. ItalyEmili Fernández-Egea, MD. Cambridge. UKCarmina R. Fumaz, Psych. D. Barcelona. SpainSaye H. Khoo, MD. Liverpool. UKScott Letendre, MD. San Diego. USA
José A. Muñoz-Moreno, Psych D. Barcelona. SpainAraceli Rousaud, Psych D. Barcelona. SpainMilton Wainberg, MD. New York. USAAlan Winston, MD. London. UK
